0001209191-17-037245.txt : 20170602
0001209191-17-037245.hdr.sgml : 20170602
20170602162252
ACCESSION NUMBER: 0001209191-17-037245
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170601
FILED AS OF DATE: 20170602
DATE AS OF CHANGE: 20170602
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Siegel Eric H.
CENTRAL INDEX KEY: 0001527573
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 17888279
MAIL ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY RD., BLDG. E336
STREET 2: C/O INCYTE CORP., EXPERIMENTAL STATION
CITY: WILMINGTON
STATE: DE
ZIP: 19880
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-01
0
0000879169
INCYTE CORP
INCY
0001527573
Siegel Eric H.
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP, General Counsel
Common Stock
2017-06-01
4
M
0
1820
64.55
A
18744
D
Common Stock
2017-06-01
4
S
0
1820
130.00
D
16924
D
Non-Qualified Stock Option (right to buy)
64.55
2017-06-01
4
M
0
1820
0.00
D
2021-01-20
Common Stock
1820
18392
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
This includes an aggregate of 11,187 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
/s/ Eric Siegel
2017-06-02